By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
- Home
- Medical Devices
- Report Detail
Global Enteric Disease Testing and Therapeutic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Enteric Disease Testing and Therapeutic companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Enteric Disease Testing and Therapeutic market. Further, it explains the major drivers and regional dynamics of the global Enteric Disease Testing and Therapeutic market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Abbott
- GlaxoSmithKline
- Becton Dickinson
- bioMérieux
- Sanofi
- Bayer Pharma
- Bio-Rad
- Quest Diagnostics
- Trinity Biotech
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Enteric Disease Testing and Therapeutic Segment by Type
- Bacterial Disease
- Viral Disease
- Parasitic Disease
Enteric Disease Testing and Therapeutic Segment by Application
- Hospital
- Specialty Clinic
- Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Enteric Disease Testing and Therapeutic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Enteric Disease Testing and Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Enteric Disease Testing and Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Enteric Disease Testing and Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Enteric Disease Testing and Therapeutic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Enteric Disease Testing and Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Enteric Disease Testing and Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, GlaxoSmithKline, Becton Dickinson, bioMérieux, Sanofi, Bayer Pharma, Bio-Rad, Quest Diagnostics and Trinity Biotech, etc.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Bacterial Disease
1.2.3 Viral Disease
1.2.4 Parasitic Disease
1.3 Market by Application
1.3.1 Global Enteric Disease Testing and Therapeutic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Enteric Disease Testing and Therapeutic Market Size (2017-2028)
2.2 Enteric Disease Testing and Therapeutic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Enteric Disease Testing and Therapeutic Market Size by Region (2017-2022)
2.4 Global Enteric Disease Testing and Therapeutic Market Size Forecast by Region (2023-2028)
2.5 Global Top Enteric Disease Testing and Therapeutic Countries Ranking by Market Size
3 Enteric Disease Testing and Therapeutic Competitive by Company
3.1 Global Enteric Disease Testing and Therapeutic Revenue by Players
3.1.1 Global Enteric Disease Testing and Therapeutic Revenue by Players (2017-2022)
3.1.2 Global Enteric Disease Testing and Therapeutic Market Share by Players (2017-2022)
3.2 Global Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Enteric Disease Testing and Therapeutic Revenue
3.4 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio
3.4.1 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enteric Disease Testing and Therapeutic Revenue in 2021
3.5 Global Enteric Disease Testing and Therapeutic Key Players Head office and Area Served
3.6 Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
3.7 Date of Enter into Enteric Disease Testing and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Enteric Disease Testing and Therapeutic Breakdown Data by Type
4.1 Global Enteric Disease Testing and Therapeutic Historic Revenue by Type (2017-2022)
4.2 Global Enteric Disease Testing and Therapeutic Forecasted Revenue by Type (2023-2028)
5 Global Enteric Disease Testing and Therapeutic Breakdown Data by Application
5.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Application (2017-2022)
5.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022)
6.2 North America Enteric Disease Testing and Therapeutic Revenue by Type (2017-2028)
6.3 North America Enteric Disease Testing and Therapeutic Revenue by Application (2017-2028)
6.4 North America Enteric Disease Testing and Therapeutic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022)
7.2 Europe Enteric Disease Testing and Therapeutic Revenue by Type (2017-2028)
7.3 Europe Enteric Disease Testing and Therapeutic Revenue by Application (2017-2028)
7.4 Europe Enteric Disease Testing and Therapeutic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022)
8.2 Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Type (2017-2028)
8.3 Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Application (2017-2028)
8.4 Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022)
9.2 Latin America Enteric Disease Testing and Therapeutic Revenue by Type (2017-2028)
9.3 Latin America Enteric Disease Testing and Therapeutic Revenue by Application (2017-2028)
9.4 Latin America Enteric Disease Testing and Therapeutic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022)
10.2 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Type (2017-2028)
10.3 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Application (2017-2028)
10.4 Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Enteric Disease Testing and Therapeutic Products and Services
11.1.4 Abbott Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.1.5 Abbott Enteric Disease Testing and Therapeutic SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Products and Services
11.2.4 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.2.5 GlaxoSmithKline Enteric Disease Testing and Therapeutic SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Products and Services
11.3.4 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.3.5 Becton Dickinson Enteric Disease Testing and Therapeutic SWOT Analysis
11.3.6 Becton Dickinson Recent Developments
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Enteric Disease Testing and Therapeutic Products and Services
11.4.4 bioMérieux Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.4.5 bioMérieux Enteric Disease Testing and Therapeutic SWOT Analysis
11.4.6 bioMérieux Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Enteric Disease Testing and Therapeutic Products and Services
11.5.4 Sanofi Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.5.5 Sanofi Enteric Disease Testing and Therapeutic SWOT Analysis
11.5.6 Sanofi Recent Developments
11.6 Bayer Pharma
11.6.1 Bayer Pharma Company Details
11.6.2 Bayer Pharma Business Overview
11.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Products and Services
11.6.4 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.6.5 Bayer Pharma Enteric Disease Testing and Therapeutic SWOT Analysis
11.6.6 Bayer Pharma Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Products and Services
11.7.4 Bio-Rad Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.7.5 Bio-Rad Enteric Disease Testing and Therapeutic SWOT Analysis
11.7.6 Bio-Rad Recent Developments
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Details
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Products and Services
11.8.4 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.8.5 Quest Diagnostics Enteric Disease Testing and Therapeutic SWOT Analysis
11.8.6 Quest Diagnostics Recent Developments
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Details
11.9.2 Trinity Biotech Business Overview
11.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Products and Services
11.9.4 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022)
11.9.5 Trinity Biotech Enteric Disease Testing and Therapeutic SWOT Analysis
11.9.6 Trinity Biotech Recent Developments
12 Enteric Disease Testing and Therapeutic Market Dynamics
12.1 Enteric Disease Testing and Therapeutic Market Trends
12.2 Enteric Disease Testing and Therapeutic Market Drivers
12.3 Enteric Disease Testing and Therapeutic Market Challenges
12.4 Enteric Disease Testing and Therapeutic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Bacterial Disease
Table 3. Key Players of Viral Disease
Table 4. Key Players of Parasitic Disease
Table 5. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Enteric Disease Testing and Therapeutic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Enteric Disease Testing and Therapeutic Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Region (2017-2022)
Table 9. Global Enteric Disease Testing and Therapeutic Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Enteric Disease Testing and Therapeutic Market Share by Players (2017-2022)
Table 11. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2021)
Table 12. Ranking of Global Top Enteric Disease Testing and Therapeutic Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Enteric Disease Testing and Therapeutic Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Enteric Disease Testing and Therapeutic Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Enteric Disease Testing and Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2017-2022)
Table 20. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2023-2028)
Table 22. Global Enteric Disease Testing and Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2017-2022)
Table 24. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2023-2028)
Table 26. North America Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Enteric Disease Testing and Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Enteric Disease Testing and Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Enteric Disease Testing and Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Enteric Disease Testing and Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Enteric Disease Testing and Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Enteric Disease Testing and Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Enteric Disease Testing and Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Enteric Disease Testing and Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Enteric Disease Testing and Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Enteric Disease Testing and Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Enteric Disease Testing and Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Enteric Disease Testing and Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Enteric Disease Testing and Therapeutic Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Enteric Disease Testing and Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Enteric Disease Testing and Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Enteric Disease Testing and Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Enteric Disease Testing and Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Enteric Disease Testing and Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Enteric Disease Testing and Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Enteric Disease Testing and Therapeutic Product and Services
Table 64. Abbott Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 65. Abbott Enteric Disease Testing and Therapeutic SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Services
Table 70. GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 71. GlaxoSmithKline Enteric Disease Testing and Therapeutic SWOT Analysis
Table 72. GlaxoSmithKline Recent Developments
Table 73. Becton Dickinson Company Details
Table 74. Becton Dickinson Business Overview
Table 75. Becton Dickinson Enteric Disease Testing and Therapeutic Product and Services
Table 76. Becton Dickinson Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 77. Becton Dickinson Enteric Disease Testing and Therapeutic SWOT Analysis
Table 78. Becton Dickinson Recent Developments
Table 79. bioMérieux Company Details
Table 80. bioMérieux Business Overview
Table 81. bioMérieux Enteric Disease Testing and Therapeutic Product and Services
Table 82. bioMérieux Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 83. bioMérieux Enteric Disease Testing and Therapeutic SWOT Analysis
Table 84. bioMérieux Recent Developments
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Enteric Disease Testing and Therapeutic Product and Services
Table 88. Sanofi Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 89. Sanofi Enteric Disease Testing and Therapeutic SWOT Analysis
Table 90. Sanofi Recent Developments
Table 91. Bayer Pharma Company Details
Table 92. Bayer Pharma Business Overview
Table 93. Bayer Pharma Enteric Disease Testing and Therapeutic Product and Services
Table 94. Bayer Pharma Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 95. Bayer Pharma Enteric Disease Testing and Therapeutic SWOT Analysis
Table 96. Bayer Pharma Recent Developments
Table 97. Bio-Rad Company Details
Table 98. Bio-Rad Business Overview
Table 99. Bio-Rad Enteric Disease Testing and Therapeutic Product and Services
Table 100. Bio-Rad Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 101. Bio-Rad Enteric Disease Testing and Therapeutic SWOT Analysis
Table 102. Bio-Rad Recent Developments
Table 103. Quest Diagnostics Company Details
Table 104. Quest Diagnostics Business Overview
Table 105. Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Services
Table 106. Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 107. Quest Diagnostics Enteric Disease Testing and Therapeutic SWOT Analysis
Table 108. Quest Diagnostics Recent Developments
Table 109. Trinity Biotech Company Details
Table 110. Trinity Biotech Business Overview
Table 111. Trinity Biotech Enteric Disease Testing and Therapeutic Product and Services
Table 112. Trinity Biotech Enteric Disease Testing and Therapeutic Revenue in Enteric Disease Testing and Therapeutic Business (2017-2022) & (US$ Million)
Table 113. Trinity Biotech Enteric Disease Testing and Therapeutic SWOT Analysis
Table 114. Trinity Biotech Recent Developments
Table 115. Enteric Disease Testing and Therapeutic Market Trends
Table 116. Enteric Disease Testing and Therapeutic Market Drivers
Table 117. Enteric Disease Testing and Therapeutic Market Challenges
Table 118. Enteric Disease Testing and Therapeutic Market Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enteric Disease Testing and Therapeutic Sales Market Share by Type: 2021 VS 2028
Figure 2. Bacterial Disease Features
Figure 3. Viral Disease Features
Figure 4. Parasitic Disease Features
Figure 5. Global Enteric Disease Testing and Therapeutic Sales Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Specialty Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Enteric Disease Testing and Therapeutic Report Years Considered
Figure 10. Global Enteric Disease Testing and Therapeutic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Enteric Disease Testing and Therapeutic Market Size 2017-2028 (US$ Million)
Figure 12. Global Enteric Disease Testing and Therapeutic Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Enteric Disease Testing and Therapeutic Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Enteric Disease Testing and Therapeutic Market Share by Players in 2021
Figure 16. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Enteric Disease Testing and Therapeutic Revenue in 2021
Figure 18. North America Enteric Disease Testing and Therapeutic Revenue Market Share by Company in 2021
Figure 19. North America Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2017-2028)
Figure 20. North America Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2017-2028)
Figure 21. North America Enteric Disease Testing and Therapeutic Revenue Share by Country (2017-2028)
Figure 22. U.S. Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Enteric Disease Testing and Therapeutic Revenue Market Share by Company in 2021
Figure 25. Europe Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2017-2028)
Figure 26. Europe Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2017-2028)
Figure 27. Europe Enteric Disease Testing and Therapeutic Revenue Share by Country (2017-2028)
Figure 28. Germany Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 29. France Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Enteric Disease Testing and Therapeutic Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Enteric Disease Testing and Therapeutic Revenue Share by Region (2017-2028)
Figure 37. China Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 40. India Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Enteric Disease Testing and Therapeutic Revenue Market Share by Company in 2021
Figure 49. Latin America Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Enteric Disease Testing and Therapeutic Revenue Share by Country (2017-2028)
Figure 52. Mexico Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Enteric Disease Testing and Therapeutic Revenue Share by Country (2017-2028)
Figure 59. Turkey Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 61. U.A.E Enteric Disease Testing and Therapeutic Revenue (2017-2028) & (US$ Million)
Figure 62. Abbott Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 64. Becton Dickinson Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 65. bioMérieux Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 66. Sanofi Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 67. Bayer Pharma Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 68. Bio-Rad Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 69. Quest Diagnostics Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 70. Trinity Biotech Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Write comment about above report:
Related Reports
|
Global Enteric Disease Testing and Therapeutic Market Research Report 2023
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is... |
|
Global Enteric Disease Testing and Therapeutic Market Insights, Forecast to 2028
Enteric Disease Testing and Therapeutic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Enteric Disease Testing and Therapeutic market will be able to gain the ... |
|
Global Enteric Disease Testing and Therapeutic Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Enteric Disease Testing and Therapeutic will have significant change from previous year. According to our (LP Information) latest study, the global Enteric Disease Testing and Therapeutic market size is... |
|
Enteric Disease Testing and Therapeutic Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type
This report describes the global market size of Enteric Disease Testing and Therapeutic from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography... |
|
Global Enteric Disease Testing and Therapeutic Market Research Report 2022
Enteric Disease Testing and Therapeutic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Enteric Disease Testing and Therapeutic market will be able to gain the ... |
|
(Post-pandemic Era) - Global Enteric Disease Testing and Therapeutic Market Segment Research Report 2022
Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really rec... |
|
Post-pandemic Era - Global Enteric Disease Testing and Therapeutic Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really rec... |
|
Global Enteric Disease Testing and Therapeutic Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2020 growth of Enteric Disease Testing and Therapeutic will have significant change from previous year. By the most conservative estimates of global Enteric Disease Testing and Therapeutic market size (most likely ... |
|
Enteric Disease Testing and Therapeutic Market Insights 2020, Global and Chinese Analysis and Forecast to 2025
Enteric Disease Testing and Therapeutic Market Insights 2020, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Enteric Disease Testing and Therapeutic industry with a focus on the Chinese market. The... |
|
Global Enteric Disease Testing and Therapeutic Market Size, Status and Forecast 2021-2027
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays